.An analysisof two Big Pharma giants shows that Pfizer only developed 10 out of 44 best-selling drugs “in house” (23%) – and Johnson & Johnson only developed 2 out of 18 (11%). The “innovation” largely happens in university and government labs, or in those of smaller research companies.
And a lot of it is state-funded. The US National Health Institutes, the main (but not the only) government medical research body, gives$39.2 billiona year to universities, medical schools and other research organisations.
Once the drugs have been found, the pharma giants step in – to buy up a license, or a whole company – once the drug has already proved itself through initial tests. (See also: recentUS reporton this.) The COVID-19 vaccines are classic examples.
cheers Greenwave.... from your site
https://corporatewatch.org/five-ways-big-pharma-makes-so-much-money/. ...... I thought be above most pertinent to some of the posts above.
imo, the competition among medical cannabis companies and the plethora of preparations is such that the Big pharmas would simply sit back and watch the battle and pick off the emerging victors as going concerns with a scalable product.
the key determinant being the profitable product, Pharma co.s may review trials reports by the most likely winners, await product launch and developments, then pick up the most profitable with, as the linked article described, the drug most likely needed for repeat prescription to a market (customer) with a chronic need of such medication and good liquidity.
No cost to the Pharma co other than the cost of buying the licence or company and tidy profits from ownership thereafter.
I think its likely IHL could get there, which is why I bought in, but that day is likely at least 4-5 years away at a guess.
ummm. not professional advice, dyor.